Patient alarm over the potential loss of subsidised access to MS medicines

If the committee advises the minister to delist the therapies on cost grounds, Health Minister Mark Butler still retains the power to set aside the advice and waive the reduction. Under the National Health Act 1953, the minister retains absolute discretion over pricing. …